Similar to our study, CD4+CD25+ regulatory T cells have been shown to increase in CHB and CHB-HCC, and they are thought to inhibit the antitumoral immune response, resulting in a tumor promoting environment (35–39). This evidence concerns the gene CD4 and hepatocellular carcinoma.